Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag after allogeneic hematopoietic stem cell transplantation for thalassemia major
ChiCTR2000032418Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of eltrombopag in beta thalassemia major (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Platelet engraftment time, Platelet transfusion dosage and 2 more. Started May 2020; status: recruiting.
02
Drugs
eltrombopag
03
Conditions
beta thalassemia major
Beyond the preview
Go deeper on ChiCTR2000032418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032418.